This activity has expired. Credit is no longer available.
This activity is supported by unrestricted educational grants from Celgene Corporation and Takeda Oncology.
Risk Stratification in Multiple Myeloma: Putting the Pieces Together
Hans Lee, MD
The University of Texas MD Anderson Cancer Center
Tiffany A. Richards, PhD, ANP, AOCNP®
The University of Texas MD Anderson Cancer Center
While the past few years have shown an unprecedented increase in the number of agents available to treat patients with multiple myeloma, many advanced practitioners struggle with optimal agent choice, timing, and sequencing, especially related to the use of these newer agents in combination regimens. Learn about these aspects of treatment, as well as testing and diagnosis, risk stratification, emerging toxicities, and supporting patients on oral therapies.
|
|
|
|
These activities, certified for CME/CE/CPE credit, are jointly provided by
  |